Cat. No. Name Size Price Add Cart
KI1432U 95666E5 mg$272
U 95666E10 mg$512
U 95666E50 mg$1552
U 95666E200 mg$3952

Chemical Characteristic

Product NameU 95666E
SynonymsSumanirole maleate
CAS No.179386-44-8
Molecular Weight 319.31
FormulaC11H13N3O.C4H4O4
Chemical Name(R)-5-(methylamino)-5,6-dihydro-1H-imidazo[4,5,1-ij]quinolin-2(4H)-one maleate
Smilesn12C[C@@H](Cc3cccc(c13)[nH]c2=O)NC C(=O)(/C=C\C(=O)O)O
Chemical Structure

Biological activities

Sumanirole maleate is a maleate of sumanirole. Sumanirole maleate is a selective D2 receptor agonist. The affinity of sumanirole for D2 receptor is 9.0 nM. Sumanirole has moderate affinity at the 5-HT1A receptor with a Ki of 95 nM. Sumanirole has greater than 200-fold selectivity for the D2 receptor subtype versus the other dopamine receptor subtypes in radioligand binding assays. In cell-based assays, sumanirole is a fully efficacious agonist, with an EC50 ranging from 17 to 75 nM. In vivo, sumanirole elicits many physiological responses attributed to D2-like receptor function. In rats, sumanirole is a full agonist for elevation of striatal acetylcholine levels with an ED50 of 12.1 mM/kg i.p.. Sumanirole s.c. dose dependently decreases plasma prolactin levels and depresses dopamine neuron firing rates in the substantia nigra pars compacta with an ED50 of 2.3 mmol/kg i.v.[1] Sumanirole maleate dose-dependently increases striatal ACh concentration both in the non-reserpinized and resetpinized rats. Sumanirole maleate also has anxiolytic activity in mice. Sumanirole maleate (3 pmol/kg po) time dependently decreases cerebellar cGMP. Pretreatment with sumanirole maleate dose-dependently attenuates stress-induced elevation in cGMP. [2] Sumanirole decreases prepulse inhibition (PPI) at 60-120 ms prepulse intervals, and increases PPI at 10-20 ms intervals. [3]

Protocols

Sumanirole maleate is dissolved in either distilled water or 0.25% methylcelhtlose sohnion. [2]

References

[1] McCall RB, et al. Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease. J Pharmacol Exp Ther. 2005, 314(3): 1248-1256.
[2] Sethy VH, U-95666E: a potential anti-parkinsonian drug with anxiolytic activity. Prog Neuropsychopharmacol Biol Psychiatry. 1997, 21(5): 873-883.
[3] Weber M, The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. Eur Neuropsychopharmacol. 2010, 20(6): 421-425.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.